$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2015 Q2 Form 10-Q Financial Statement

#000156459015006064 Filed on August 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $123.8K $43.75K
YoY Change 182.86% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.890M $6.080M
YoY Change 29.77% 198.04%
% of Gross Profit
Research & Development $7.490M $6.392M
YoY Change 17.18% 263.91%
% of Gross Profit
Depreciation & Amortization $800.0K $276.1K
YoY Change 189.8% -39.21%
% of Gross Profit
Operating Expenses $16.12M $12.74M
YoY Change 26.47% 98.08%
Operating Profit -$15.99M -$12.70M
YoY Change 25.93% 98.75%
Interest Expense $162.4K $226.4K
YoY Change -28.29% -2364.24%
% of Operating Profit
Other Income/Expense, Net $57.65K $1.074M
YoY Change -94.63% 405.87%
Pretax Income -$15.94M -$11.63M
YoY Change 37.07% 88.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.94M -$11.63M
YoY Change 37.06% 91.26%
Net Earnings / Revenue -12877.62% -26575.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$267.9K -$224.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.5M $188.5M
YoY Change -41.37% 469.39%
Cash & Equivalents $87.25M $138.3M
Short-Term Investments $23.30M $50.12M
Other Short-Term Assets $4.200M $1.200M
YoY Change 250.0% 9.09%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $114.7M $163.4M
YoY Change -29.8% 374.85%
LONG-TERM ASSETS
Property, Plant & Equipment $4.100M $3.700M
YoY Change 10.81% -2.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.100M $26.30M
YoY Change -95.82%
Other Assets $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $30.50M $33.20M
YoY Change -8.13% 369.09%
TOTAL ASSETS
Total Short-Term Assets $114.7M $163.4M
Total Long-Term Assets $30.50M $33.20M
Total Assets $145.2M $196.6M
YoY Change -26.14% 373.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.900M $2.200M
YoY Change 122.73% 107.17%
Accrued Expenses $2.600M $1.700M
YoY Change 52.94% 140.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $300.0K
YoY Change -33.33% -72.73%
Total Short-Term Liabilities $9.532M $8.300M
YoY Change 14.85% 24.29%
LONG-TERM LIABILITIES
Long-Term Debt $600.0K $800.0K
YoY Change -25.0% -33.33%
Other Long-Term Liabilities $347.0K $1.800M
YoY Change -80.72% 433.2%
Total Long-Term Liabilities $4.913M $2.600M
YoY Change 88.98% 72.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.532M $8.300M
Total Long-Term Liabilities $4.913M $2.600M
Total Liabilities $14.45M $10.30M
YoY Change 40.25% 25.88%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $151.9K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $131.3M $186.4M
YoY Change
Total Liabilities & Shareholders Equity $145.2M $196.6M
YoY Change -26.14% 373.87%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$15.94M -$11.63M
YoY Change 37.06% 91.26%
Depreciation, Depletion And Amortization $800.0K $276.1K
YoY Change 189.8% -39.21%
Cash From Operating Activities -$13.10M -$9.800M
YoY Change 33.67% 84.91%
INVESTING ACTIVITIES
Capital Expenditures -$3.200M -$700.0K
YoY Change 357.14% 250.0%
Acquisitions
YoY Change
Other Investing Activities $7.200M $1.600M
YoY Change 350.0% -139.02%
Cash From Investing Activities $4.000M $1.000M
YoY Change 300.0% -123.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.400M
YoY Change -100.0% -87.54%
NET CHANGE
Cash From Operating Activities -13.10M -9.800M
Cash From Investing Activities 4.000M 1.000M
Cash From Financing Activities 0.000 4.400M
Net Change In Cash -9.100M -4.400M
YoY Change 106.82% -117.12%
FREE CASH FLOW
Cash From Operating Activities -$13.10M -$9.800M
Capital Expenditures -$3.200M -$700.0K
Free Cash Flow -$9.900M -$9.100M
YoY Change 8.79% 78.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
46407
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
884373
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
71875
CY2015Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1724468
CY2015Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
216653
CY2015Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
595516
arwr Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
10142786
CY2015Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3970931
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
16
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7490400
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-58878
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-95132
us-gaap Net Income Loss
NetIncomeLoss
-67197746
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59492867
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44565008
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-15936053
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
226424
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
346996
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4913443
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
78702
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
19195
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15993706
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
16117456
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
990929
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
459691
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
31639
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4480
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1135651
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2328360
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2155033
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9532488
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12700100
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
43126
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
12743850
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-65947
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
151868
CY2014Q3 us-gaap Notes Payable Current
NotesPayableCurrent
50000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
423182550
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19114444
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-45257797
CY2014Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2454449
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
276054
CY2015Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-104713
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
162366
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
741058
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several bank accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p></div>
CY2014Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
758469
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2446403
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1073649
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5712335
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
482904
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81269
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11626451
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3546398
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
597896
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10054
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
386392
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
57653
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15936053
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-11626451
us-gaap Profit Loss
ProfitLoss
-67197746
us-gaap Profit Loss
ProfitLoss
-36294880
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2468
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-15936053
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-11628919
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2486074
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11628919
us-gaap Net Income Loss
NetIncomeLoss
-36199748
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51931989
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56631297
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1982
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15938035
arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
270625
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6706009
CY2015Q2 us-gaap Purchase Obligation
PurchaseObligation
51000000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.99
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.36
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12.03
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.46
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.72
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10487890
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5894091
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-65947
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0146
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0188
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75
us-gaap Interest Paid
InterestPaid
11153
us-gaap Interest Paid
InterestPaid
21478
arwr Common Stock Issued For Asset Acquisition
CommonStockIssuedForAssetAcquisition
25000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-67263693
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36199748
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25734789
CY2014 arwr Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
10148044
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2730000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5696173
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5956079
CY2014 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1303911
arwr Exchange Rights Exercised During Period Value
ExchangeRightsExercisedDuringPeriodValue
3072
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
945114
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
416291
arwr Non Cash Gain In Equity Investment
NonCashGainInEquityInvestment
87197
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-75000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
620395
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
517986
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2902368
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
138650
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-53687381
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24496567
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
10000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1251987
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
500
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46365528
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
19411146
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6590824
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8275995
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41026691
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
160162
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
257178
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
172641720
arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
313751
arwr Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
12374005
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
153589
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
184758547
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
119235289
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138349733
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
944935
CY2015Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
944935
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123191
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2014Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2015Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2015Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
372401
CY2014Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
334162
CY2015Q2 arwr Research Equipment
ResearchEquipment
5552187
CY2014Q3 arwr Research Equipment
ResearchEquipment
4614176
CY2015Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
110428
CY2014Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2015Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3117537
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
3045022
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9152553
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8062983
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5043886
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4190230
CY2015Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
24365922
CY2015Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
237577
CY2015Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
24128345
CY2014Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
44741378
CY2014Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
407523
CY2014Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
44333855
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438770
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
607801
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13663
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40990
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
438771
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1714313
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700429
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700429
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700429
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700429
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
15363151
CY2013Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2014 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2172387
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3071672
CY2013Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.86
CY2013Q4 arwr Conversion Price Per Share
ConversionPricePerShare
5.86
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60000000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6325000
CY2014Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.95
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112600000
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1437011
CY2015Q2 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
182000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
544000
CY2014Q2 arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
138000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
403000
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
57105
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
228420
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54653
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68538
arwr Assets Acquired Finite Lived Intangible Assets
AssetsAcquiredFiniteLivedIntangibleAssets
24857214
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24317951
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3240513
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2172387
CY2015Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2015Q2 arwr Threshold Percentage Of Common Stock Ownership Upon Preferred Stock Conversion
ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion
0.0999
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
228420
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
228420
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
95175
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
25371
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
812169
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
146060
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
596877
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
613664
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
637897
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
459633
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2454131
CY2015Q2 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
0
CY2015Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
13000000
CY2015Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
38000000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3419285
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1039000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
152582
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
454863
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3850840
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1670000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
95948
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
17500
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5407392
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2416134
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.05
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.05
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each RSU will be exchanged for one share of the Company’s Common Stock. Restricted stock unit awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2015Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-102763
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2268798
CY2014Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
737072
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5680540
arwr Term Of Exchange Rights
TermOfExchangeRights
P7Y
CY2013Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2375658

Files In Submission

Name View Source Status
0001564590-15-006064-index-headers.html Edgar Link pending
0001564590-15-006064-index.html Edgar Link pending
0001564590-15-006064.txt Edgar Link pending
0001564590-15-006064-xbrl.zip Edgar Link pending
arwr-10q_20150630.htm Edgar Link pending
arwr-20150630.xml Edgar Link completed
arwr-20150630.xsd Edgar Link pending
arwr-20150630_cal.xml Edgar Link unprocessable
arwr-20150630_def.xml Edgar Link unprocessable
arwr-20150630_lab.xml Edgar Link unprocessable
arwr-20150630_pre.xml Edgar Link unprocessable
arwr-ex311_9.htm Edgar Link pending
arwr-ex312_8.htm Edgar Link pending
arwr-ex321_10.htm Edgar Link pending
arwr-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending